Safety and Efficacy of PDpoetin for Management of Anemia in Patients with end Stage Renal Disease on Maintenance Hemodialysis: Results from a Phase IV Clinical Trial

Recombinant human erythropoietin (rHuEPO) is available for correcting anemia. PDpoetin, a new brand of rHuEPO, has been certified by Food and Drug Department of Ministry of Health and Medical Education of Iran for clinical use in patients with chronic kidney disease. We conducted this post-marketing...

Descripción completa

Detalles Bibliográficos
Autores principales: Javidan, Abbas Norouzi, Shahbazian, Heshmatollah, Emami, Amirhossein, Yekaninejad, Mir Saeed, Emami-Razavi, Hassan, Farhadkhani, Masoumeh, Ahmadzadeh, Ahmad, Gorjipour, Fazel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4194381/
https://www.ncbi.nlm.nih.gov/pubmed/25317316
http://dx.doi.org/10.4081/hr.2014.5195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4194381/
https://www.ncbi.nlm.nih.gov/pubmed/25317316
http://dx.doi.org/10.4081/hr.2014.5195

Ejemplares similares